Literature DB >> 26984803

Juvenile Fibromyalgia: Different from the Adult Chronic Pain Syndrome?

Susmita Kashikar-Zuck1, Christopher King2, Tracy V Ting3, Lesley M Arnold4.   

Abstract

While a majority of research has focused on adult fibromyalgia (FM), recent evidence has provided insights into the presence and impact of FM in children and adolescents. Commonly referred as juvenile fibromyalgia (JFM), youths, particularly adolescent girls, present with persistent widespread pain and cardinal symptoms observed in adult FM. A majority of youth with JFM continue to experience symptoms into adulthood, which highlights the importance of early recognition and intervention. Some differences are observed between adult and juvenile-onset FM syndrome with regard to comorbidities (e.g., joint hypermobility is common in JFM). Psychological comorbidities are common but less severe in JFM. Compared to adult FM, approved pharmacological treatments for JFM are lacking, but non-pharmacologic approaches (e.g., cognitive-behavioral therapy and exercise) show promise. A number of conceptual issues still remain including (1) directly comparing similarities and differences in symptoms and (2) identifying shared and unique mechanisms underlying FM in adults and youths.

Entities:  

Keywords:  Adolescents; Chronic widespread pain (CWP); Fibromyalgia (FM); Juvenile fibromyalgia (JFM); Juvenile primary fibromyalgia syndrome (JPFS)

Mesh:

Year:  2016        PMID: 26984803     DOI: 10.1007/s11926-016-0569-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  57 in total

1.  Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study.

Authors:  Lesley M Arnold; Piercarlo Sarzi-Puttini; Pierre Arsenault; Tahira Khan; Pritha Bhadra Brown; Andrew Clair; Joseph M Scavone; Joseph Driscoll; Jaren Landen; Lynne Pauer
Journal:  J Rheumatol       Date:  2015-06-01       Impact factor: 4.666

2.  Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up.

Authors:  D M Siegel; D Janeway; J Baum
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

3.  Fibromyalgia syndrome: experience in a pediatric rheumatology clinic.

Authors:  A Gedalia; C O García; J F Molina; N J Bradford; L R Espinoza
Journal:  Clin Exp Rheumatol       Date:  2000 May-Jun       Impact factor: 4.473

4.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

5.  Assessment of nonarticular tenderness and prevalence of fibromyalgia in children.

Authors:  D Buskila; J Press; A Gedalia; M Klein; L Neumann; R Boehm; S Sukenik
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

6.  Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndrome.

Authors:  Susmita Kashikar-Zuck; Anne M Lynch; T Brent Graham; Nicole F Swain; Sara M Mullen; Robert B Noll
Journal:  Arthritis Rheum       Date:  2007-04-15

Review 7.  Exercise for treating fibromyalgia syndrome.

Authors:  A J Busch; K A R Barber; T J Overend; P M J Peloso; C L Schachter
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

8.  Prevalence of fibromyalgia in children: a clinical study of Mexican children.

Authors:  P Clark; R Burgos-Vargas; C Medina-Palma; P Lavielle; F F Marina
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

9.  The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains.

Authors:  James W Varni; Tasha M Burwinkle; Christine A Limbers; Ilona S Szer
Journal:  Health Qual Life Outcomes       Date:  2007-02-12       Impact factor: 3.186

10.  Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.

Authors:  Lesley M Arnold; Lucinda Bateman; Robert H Palmer; Yuhua Lin
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-26       Impact factor: 3.054

View more
  14 in total

Review 1.  Evaluating psychosocial contributions to chronic pain outcomes.

Authors:  S M Meints; R R Edwards
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-01-31       Impact factor: 5.067

Review 2.  Fibromyalgia: Treating Pain in the Juvenile Patient.

Authors:  Sabrina Gmuca; David D Sherry
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

Review 3.  [Definition, diagnostics and therapy of chronic widespread pain and the (so-called) fibromyalgia syndrome in children and adolescents : Updated guidelines 2017].

Authors:  N Draheim; F Ebinger; E Schnöbel-Müller; B Wolf; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

4.  Prevalence of Juvenile Fibromyalgia Syndrome Among Children and Adolescents and its Relationship With Academic Success, Depression and Quality of Life, Çorum Province, Turkey.

Authors:  Ayla Çagliyan TÜrk; Füsun Şahİn
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

Review 5.  Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis.

Authors:  Maya Levy Coles; Yosef Uziel
Journal:  Pediatr Rheumatol Online J       Date:  2021-05-18       Impact factor: 3.054

6.  Improvements in Sleep Correlate With Improvements in Clinical Outcomes Among Adolescents Undergoing Intensive Interdisciplinary Pain Treatment.

Authors:  Ian A Boggero; Kendra N Krietsch; Hannah M Pickerill; Kelly C Byars; Kendra J Homan; Sara E Williams; Christopher D King
Journal:  Clin J Pain       Date:  2021-06-01       Impact factor: 3.423

Review 7.  Juvenile Fibromyalgia and Headache Comorbidity in Children and Adolescents: A Literature Review.

Authors:  Emilia Matera; Roberto Palumbi; Antonia Peschechera; Maria Giuseppina Petruzzelli; Vittorio Sciruicchio; Marina de Tommaso; Lucia Margari
Journal:  Pain Res Manag       Date:  2019-06-03       Impact factor: 3.037

8.  Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.

Authors:  Jennifer E Weiss; Kenneth N Schikler; Alexis D Boneparth; Mark Connelly
Journal:  Pediatr Rheumatol Online J       Date:  2019-07-26       Impact factor: 3.054

9.  Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center.

Authors:  Marina de Tommaso; Vittorio Sciruicchio; Marianna Delussi; Eleonora Vecchio; Marvita Goffredo; Michele Simeone; Maria Grazia Foschino Barbaro
Journal:  J Headache Pain       Date:  2017-05-30       Impact factor: 7.277

10.  Special considerations in conducting clinical trials of chronic pain management interventions in children and adolescents and their families.

Authors:  Tonya M Palermo; Susmita Kashikar-Zuck; Stefan J Friedrichsdorf; Scott W Powers
Journal:  Pain Rep       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.